1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Eden Empire Inc.

Eden Empire Inc.

EDNEF
Eden Empire Inc.US flagOther OTC
0.00
USD
- -
- -
68,588.00Market Cap
2019 Y
2020 Y
2021 Y
TTM
Revenue per Share
- -
- -
- -
- -
Basic EPS, GAAP
-0.02
-0.05
-0.04
-0.04
Free Cash Flow per Basic Share
-0.01
-0.04
-0.03
-0.02
Dividend per Share
- -
- -
- -
- -
Book Value per Share
- -
0.03
- -
-0.01
Tangible Book Value per Share
- -
0.03
- -
-0.02
Basic Weighted Avg Shares
92
92
94
114
Sales/Revenue/Turnover
- -
- -
- -
- -
Operating Margin (%)
- -
- -
-1,324.84
-1,182.68
Depreciation Expense
- -
- -
1
1
Net Income, GAAP
-2
-5
-4
-5
Effective Tax Rate (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-1,818.92
-1,716.85
Working Capital
5
- -
-2
-5
LT Debt
6
1
- -
1
Total Equity
- -
3
- -
-1
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Oct'22
Jan'22
Apr'22
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
101
126
137
Market Capitalization
5
4
5

Working Capital

FRC

•

in mil. unless spec.
Oct'22
Jan'22
Apr'22
Total Current Assets
2
2
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
4
6
6
Payables & Accruals
1
2
3
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-88.2%
Free Cash Flow
- -
- -
-20.14%
Net Income, GAAP
- -
- -
-17.33%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.01
-0.01
- -
- -
-0.05
2021
-0.01
-0.01
-0.01
- -
-0.04
2022
-0.01
-0.01
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
David Gdanski
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
408 – 150 24th Street Vancouver BC Canada V7V 4G8
IPO Date
Aug 19, 2021
Website
myeden.ca
Similar Companies
Willow Biosciences Inc. (WLLW.TO)
Cannara Biotech Inc. (LOVE.V)
Aspen Pharmacare Holdings Limited (APNHF)
China Resources Jiangzhong Pharmaceutical Co.,Ltd (600750.SS)
PsyRX CNS Bio-Tech Ltd (PSRX.TA)
Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L)
Business
Eden Empire Inc. strategically invests in and manages operations across the burgeoning cannabis industry. The company is actively involved in the retail distribution of cannabis products throughout Canada and the United States, particularly focusing its expansion efforts within Michigan. Beyond its retail footprint, Eden Empire Inc. aims to cultivate, extract, and process cannabis, pursuing a fully integrated product model. The Vancouver, Canada-based entity distinguishes itself with a unique "street-style" brand approach for the recreational market.